Joy Behar’s comments on TrumpRx reveal the mindset of the elite

Joy Behar had a bit of a meltdown on “The View,” illustrating why out-of-touch celebrities often misunderstand everyday struggles for American families. During a recent show, she dramatically proclaimed, “we’re all going to die,” as President Trump was beginning his speech regarding a new initiative aimed at lowering prescription drug prices.

While Behar focuses on her concerns in a seemingly isolated bubble, countless parents are left to choose between buying groceries and essential medicines for their ailing children.

There’s a sense of relief in knowing that lowering prescription drug prices—by cutting out the middlemen and advocating for better deals—isn’t the doomsday scenario Behar suggests.

She expressed fears that Trump is merely using the TrumpRx initiative to promote himself, declaring ominously, “We are all going to die.” Really?

Co-host Sunny Hostin joined in, suggesting that Trump’s motives are purely financial. “He’s not doing this out of good intentions,” she stated to a national audience, “He’s doing this to make money.”

However, it’s worth noting that Trump isn’t profiting from TrumpRx. He receives no commissions or royalties from this initiative, which is actually a government-operated portal, as indicated by the website’s official address.

TrumpRx offers significant peace of mind through consumer discounts and partnerships like Mark Cuban’s Cost Plus Drugs, cutting out middlemen and maximizing savings.

Think about families with serious health issues. Take, for instance, the innovative gene therapy from Regeneron for a rare form of hearing loss. Through TrumpRx, it’s available for free to American families, allowing kids to restore their hearing without financial burdens.

For families dealing with juvenile idiopathic arthritis or Crohn’s disease, medication like Humira could now cost around $950 per dose instead of a staggering $7,000. This kind of financial relief lets children stay active and avoid painful flare-ups.

Moreover, fertility treatments that were once hundreds of dollars are now priced much lower, facilitating family planning. Medications for chronic conditions like COPD and asthma have also seen substantial price drops—making a tangible difference for many families.

For countless households, these savings translate directly to relief and accessibility. TrumpRx is slashing costs for a range of brand-name and generic medications affecting people of all ages. Parents no longer need to skip refill appointments out of financial concern. Unfortunately, Behar’s disdain for Trump seems to obscure her understanding of these challenges faced by working families.

That’s where the real issue lies.

It appears that the women on “The View” aren’t irate about the soaring costs of medication—they’re more upset that Trump found a way to lower them and is being recognized for it. Their political perspectives seem to take precedence over the families who are genuinely benefiting.

For frontline nurses, it’s tough to witness. Families aren’t worried about receiving discounted medications branded with Trump’s name. Their primary concern is ensuring they can afford prescriptions, meet their financial obligations, and keep their kids healthy.

While TrumpRx might not be perfect and lacks more extensive government programs, the focus on reducing drug prices isn’t a catastrophe. In fact, it should be a relief.

Behar and Hostin can scoff from their studio as much as they want. The parents at the pharmacy counter understand the stakes much better.